Cyclin-Dependent Kinases(细胞周期蛋白依赖性激酶)
Cyclin-dependent kinases is a group of serine/threonine kinases. It is activated by binding to cyclin and participates in the regulation of cell cycle.
Products for Cyclin-Dependent Kinases
- Cat.No. 产品名称 Information
- GC50175 CGP 74514 dihydrochloride Potent cdk1 inhibitor
-
GC15841
Alsterpaullone
阿特波龙,9-Nitropaullone,NSC 705701
A dual CDK and GSK3 inhibitor -
GC16520
Olomoucine
2-(2'-羟基乙基氨基)-9-甲基-6-(苄基氨基)嘌呤
An inhibitor of cyclin-dependent kinases -
GC15215
Iso-Olomoucine
异奥罗莫星
An inactive stereoisomer of olomoucine -
GC14294
Cdk1/2 Inhibitor III
Cyclin-dependent kinase 1/2 Inhibitor III
A cell-permeable inhibitor of Cdk1 and Cdk2 -
GC11564
Cdk4/6 Inhibitor IV
CINK4
A cell-permeable inhibitor of Cdk4/6 -
GC15607
ON123300
8-环戊基-7,8-二氢-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈,ON123300
A multi-kinase inhibitor - GC14002 Bohemine A Cdk inhibitor
-
GC15173
PD 0332991 (Palbociclib)
帕布昔利布(palbociclib),PD0332991;PD-0332991;PD 0332991
PD 0332991 (Palbociclib) (PD 0332991) 是一种具有口服活性的选择性 CDK4 和 CDK6 抑制剂,IC50 值分别为 11 和 16 nM。 PD 0332991 (Palbociclib) 具有有效的抗增殖活性,可诱导癌细胞的细胞周期停滞,可用于 HR 阳性和 HER2 阴性乳腺癌和肝细胞癌的研究。 -
GC18051
CCT251545 analogue, Compound 51
Potent, Selective, orally bioavailable CDK 8/19 Inhibitor
- GC16420 THZ531 An inhibitor of Cdk12 and Cdk13
-
GC14230
K03861
AUZ454或者K03861,K03861
K03861 (K03861) 是一种 II 型 CDK2 抑制剂,Kd 为 8.2 nM。 K03861 (K03861) 通过与活化细胞周期蛋白的结合竞争抑制 CDK2 活性。 - GC16545 GX-674 GX-674 是一种有效的、状态依赖性、异构体选择性电压门控钠通道 1.7 (Nav1.7) 拮抗剂,在 -40 mV 时的 IC50 为 0.1 nM。
- GC13511 THZ2 A Cdk7 inhibitor
-
GC12826
AZD-5597
[4-[[5-氟-4-[2-甲基-1-(1-甲基乙基)-1H-咪唑-5-基]-2-嘧啶基]氨基]苯基][(3S)-3-(甲氨基)-1-吡咯烷]甲酮
Potent CDK inhibitor
-
GC14707
Purvalanol A
NG-60
A selective inhibitor of cyclin-dependent kinases -
GC12348
Ro 3306
2-[[(噻吩-2-基)甲基]氨基]-5-[1-(喹啉-6-基)甲-(Z)-亚基]噻唑-4-酮
An inhibitor of Cdk1 - GC11971 LY2857785 A Cdk9 inhibitor
-
GC17067
LDC000067
(3-(6-(2-甲氧基苯基)嘧啶-4-基氨基)苯基)甲烷磺酰胺,LDC067
A Cdk9 inhibitor - GC11944 PF 4800567 hydrochloride A selective CK1ε inhibitor
-
GC16413
TMCB
4,5-二氢-N-(2,3,5,6-四溴-4-甲氧基苯基)-1H-咪唑-2-甲酰胺
A dual inhibitor of CK2 and ERK8 - GC16429 (R)-DRF053 dihydrochloride cdk/CK1 inhibitor,potent and ATP-competitive
-
GC17150
Ryuvidine
Cdk4 Inhibitor III, Cyclic-dependent Kinase 4 Inhibitor III, SPS812
An inhibitor of SETD8 -
GC12886
NSC 625987
Cdk4 Inhibitor II
A Cdk4/cyclin D1 complex inhibitor -
GC11410
Aminopurvalanol A
NG 97
A selective CDK inhibitor -
GC11634
NSC 693868
1H-吡唑并[3,4-B]喹喔啉-3-胺,Cdk1/5 Inhibitor
A selective inhibitor of Cdk1 and Cdk5 - GC13100 [Ala92]-p16 (84-103) inhibitor of cyclin-dependent kinase-4 (cdk4)/cyclin D1
- GC13649 Arcyriaflavin A A CDK4 and CAMKII inhibitor
-
GC14182
Kenpaullone
克莱拉尼,9-Bromopaullone; NSC-664704
A inhibitor of cyclin-dependent kinase and GSK3β - GC12642 THZ1 Hydrochloride A covalent Cdk7 inhibitor
-
GC14162
ML167
5-[4-[[(5-甲基-2-呋喃基)甲基]氨基]-6-喹唑啉基]-2-呋喃甲醇,CID44968231; NCGC00188654
A selective Clk4 inhibitor - GC10840 THZ1 A covalent Cdk7 inhibitor
-
GC15377
LEE011 succinate
瑞博西尼琥珀酸盐; LEE011 succinate
A selective cyclin D1/CDK4 and cyclin D3/CDK6 inhibitor -
GC15922
LEE011 hydrochloride
瑞博西尼盐酸盐; LEE011 hydrochloride
A selective cyclin D1/CDK4 and cyclin D3/CDK6 inhibitor -
GC11785
CDK4 inhibitor
瑞博西尼
An antiproliferative cyclin D1/Cdk4 inhibitor - GC14974 AMG 925 A dual inhibitor of FLT3 and Cdk4
-
GC16000
WHI-P180
3-[(6,7-二甲氧基-4-喹唑啉基)氨基]苯酚,Janex 3
A multi-kinase inhibitor -
GC17400
R547
[4-氨基-2-[(1-甲磺酰基哌啶-4-基)氨基]嘧啶-5-基](2,3-二氟-6-甲氧基苯基)甲酮
A selective Cdk inhibitor -
GC10842
LEE011
瑞博西尼; LEE011
A selective cyclin D1/CDK4 and cyclin D3/CDK6 inhibitor -
GC16425
Flavopiridol hydrochloride
(-)-2-(2-氯苯基)-5,7-二羟基-8-[(3S,4R)-3-羟基-1-甲基-4-哌啶基]-4H-1-苯并吡喃-4-酮盐酸盐,Alvocidib Hydrochloride; L86-8275 Hydrochloride; HMR-1275 Hydrochloride
An inhibitor of cyclin-dependent kinases -
GC11835
Deferasirox
地拉罗司; ICL 670
An iron chelator with anticancer activity -
GC16268
Purvalanol B
(2R)-2-[[6-[(3-氯-4-羧基苯基)氨基]-9-(1-甲基乙基)-9H-嘌呤-2-基]氨基]-3-甲基-1-丁醇,NG 95; NG95; NG-95
A CDK inhibitor -
GC17648
Dinaciclib(SCH727965)
(2S)-1-[3-乙基-7-[[(1-氧代-3-吡啶基)甲基]氨基]吡唑并[1,5-A]嘧啶-5-基]-2-哌啶乙醇,SCH 727965
A CDK inhibitor - GC12865 BMS265246 A cell-permeable inhibitor of Cdk1 and Cdk2
-
GC15588
PHA-848125
PHA-848125
An inhibitor of Cdks -
GC15421
Palbociclib (PD0332991) Isethionate
帕博西尼羟乙基磺酸盐; PD 0332991 isethionate
Palbociclib (PD 0332991) isethionate 是一种具有口服活性的选择性 CDK4 和 CDK6 抑制剂,IC50 值分别为 11 和 16 nM。 Palbociclib (PD0332991) Isethionate 具有有效的抗增殖活性,可诱导癌细胞的细胞周期停滞,可用于 HR 阳性和 HER2 阴性乳腺癌和肝细胞癌的研究。 -
GC12438
AZD-5438
4-[2-甲基-1-异丙基-1H-咪唑-5-基]-N-[4-(甲磺酰基)苯基]-2-嘧啶胺,AZD 5438;AZD5438
A potent inhibitor of CDKs -
GC17935
PD 0332991 (Palbociclib) HCl
帕布昔利布盐酸盐,PD0332991;PD-0332991;PD 0332991
PD 0332991 作为 CDK4 和 CDK6 激酶的口服活性强效和高选择性抑制剂,可以在低纳摩尔浓度下阻断 pRb 磷酸化并随后在敏感细胞系中诱导 G1 期停滞。 -
GC16822
LY2835219
Abemaciclib; LY2835219 methanesulfonate
LY2835219 free base是 CDK4 和 CDK6 的强效选择性抑制剂,在非细胞实验中的 IC50 分别为 2nM 和 10nM。 - GC15963 Nu 6027 A CDK and ATR inhibitor